Don’t miss outtag icon
Get early access to Digital 100 2026, Similarweb’s official ranking of the fastest-growing brandsPre-register now!banner icon
Mereo BioPharma Group PLC

November 2025

  • Home
  • Mereo BioPharma Group PLC

Mereo BioPharma Group PLC Market Share Analysis for November 2025

London, May 15, 2024 - Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), , today announced its financial results for the first quarter ended March 31, 2024, and provided an update on recent corporate highlights.
Year Founded2015
Employees51 - 200
Annual Revenue$25M - $50M
mereobiopharma.com
Mereo BioPharma Group PLC
Mereo BioPharma Group PLC (including company regionals)
  • mereobiopharma.com
    mereobiopharma.com
See more website traffic and engagement information

Mereo BioPharma Group PLC Revenue up to November 2025 is 25M - 50M

revenue generated by Mereo BioPharma Group PLC top domains

Mereo BioPharma Group PLC top domains revenue over 3 years

Revenue for Mereo BioPharma Group PLC top domains

mereobiopharma.commereobiopharma.com25M - 50M
See more with Sales Intelligence

Total visits to Mereo BioPharma Group PLC's top domains

Understand Mereo BioPharma Group PLC market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Mereo BioPharma Group PLC's top domains

Analyze Mereo BioPharma Group PLC engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown
mereobiopharma.commereobiopharma.com00:05:00
See more with Sales Intelligence

Avg. pageviews on Mereo BioPharma Group PLC's top domains

See how Mereo BioPharma Group PLC keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown
mereobiopharma.commereobiopharma.com1.59
See more with Sales Intelligence

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Mereo BioPharma Group PLC

These are the website technologies, by industry, used by Mereo BioPharma Group PLC top domains

Marketing (3)

Google Marketing Platform

Google Marketing Platform

Advertising (2)

DoubleClick

DoubleClick

Conversion & Analytics (2)

Google Analytics

Google Analytics

Email Services (2)

Microsoft Exchange Online

Microsoft Exchange Online

More Technologies

9

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Mereo BioPharma Group PLC

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMereo BioPharma Group is planning to go public.In other recent news, Mereo BioPharma Group plc announced the pricing of a public offering of approximately 12,531,300 American Depositary Shares (ADSs) expected to raise gross proceeds of about $50 million.
News– Krishnan leaves Mereo BioPharma Group as Head and Senior Vice President of Clinical Development.Suba Krishnan, M.D., Vice President, Early Development Lead – Krishnan joined from Mereo BioPharma, where she served as the Head and Senior Vice President of Clinical Development.
NewsMereo BioPharma Group launched updated clinical data from open-label Phase 1b/2 Study of Etigilimab and Nivolumab on Jun 2nd '22.Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or “the Company”), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced updated clinical data from its open-label Phase 1b/2 Study of Etigilimab and Nivolumab in subjects with Select Locally Advanced or Metastatic Solid Tumors (ACTIVATE).

See all Mereo BioPharma Group PLC signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.